Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
13 avr. 2022 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Diabetic Foot Ulcer Market Size Worth $7,793.83 Mn, Globally, by 2028 at 7.9% CAGR - Exclusive Report by The Insight Partners
11 févr. 2022 08h51 HE
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Diabetic Foot Ulcer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Advanced Wound Care Dressings,...
Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
06 janv. 2022 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound System
13 déc. 2021 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Launches Experts in Wound Care Program
18 oct. 2021 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics
21 sept. 2021 10h41 HE
|
Innosphere Ventures
Golden, CO and Fort Collins, CO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage...
Integra LifeSciences Announces Positive Clinical Outcomes for PriMatrix® Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers
19 juil. 2021 16h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical outcomes...
Global Skin and Wound Care Market Is Expected to Reach USD 25.98 Billion by 2025 : Fior Markets
04 mars 2020 08h00 HE
|
Fior Markets
Newark, NJ, March 04, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global skin and wound care market is expected to grow from USD 18.49 Billion in 2017 to USD 25.98...
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
24 janv. 2019 10h00 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Smith & Nephew wins prestigious Galien Award for PICO Negative Pressure Wound Therapy innovation
21 déc. 2016 03h30 HE
|
Smith & Nephew Plc
PARIS, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Smith & Nephew, (LSE:SN) (NYSE:SNN), the global medical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use...